Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bronchial Cancer”

8,165 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 8,165 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04603807
What this trial is testing

Compare the Efficacy and Safety of Entrectinib and Crizotinib in Participants With Advanced or Metastatic ROS1 Non-small Cell Lung Cancer (NSCLC) With and Without Central Nervous System (CNS) Metastases

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Hoffmann-La Roche 217
Large-scale testing (Phase 3)Study completedNCT00775307
What this trial is testing

Adjuvant Pazopanib in Stage I NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Intergroupe Francophone de Cancerologie Thoracique 142
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07679607
What this trial is testing

GCC 2545- Improving Post-Radiotherapy Respiratory Function Through Sparing Serial and Parallel Components in the Lung

Who this might be right for
Lung Cancer (NSCLC)Radiation
University of Maryland, Baltimore 70
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06648200
What this trial is testing

Toripalimab and JS004 Combined With Platinum-based Chemotherapy for Relapsed and Extensive-stage Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer Extensive StageSmall Cell Lung Cancer Recurrent
Shanghai Pulmonary Hospital, Shanghai, China 100
Post-approval studies (Phase 4)UnknownNCT01926171
What this trial is testing

Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

Who this might be right for
Non-small-cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 80
Testing effectiveness (Phase 2)Study completedNCT03046992
What this trial is testing

Clinical Trial of YH25448 in Patients with EGFR Mutation Positive Advanced NSCLC

Who this might be right for
EGFR Gene Mutation
Yuhan Corporation 224
Not applicableLooking for participantsNCT06930807
What this trial is testing

Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer

Who this might be right for
Non-small Cell Lung CancerMinimal Residual DiseaseAdaptive Treatment
Peking University People's Hospital 1,000
Early research (Phase 1)UnknownNCT03050411
What this trial is testing

Apatinib Combine With EGFR-TKI for Advanced EGFR-TKI-resistant Non-Small Cell Lung Cancer

Who this might be right for
Nonsmall Cell Lung Cancer
Peking University Third Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01610336
What this trial is testing

A Safety and Efficacy Study of INC280 and Gefitinib in Patients With EGFR Mutated, c-MET-amplified NSCLC Who Have Progressed After EGFRi Treatment

Who this might be right for
Non-small Cell Lung Cancer
Novartis Pharmaceuticals 161
Not applicableLooking for participantsNCT06843707
What this trial is testing

Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics.

Who this might be right for
Lung CancerLungLung Cancer (NSCLC)+1 more
The First Affiliated Hospital of Guangzhou Medical University 2,500
Testing effectiveness (Phase 2)Study completedNCT00192036
What this trial is testing

Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Eli Lilly and Company 49
Testing effectiveness (Phase 2)UnknownNCT05055167
What this trial is testing

Envafolimab as First-line Treatment of Aged Patients in Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IV
The First Affiliated Hospital of Xiamen University 20
Not applicableLooking for participantsNCT06221800
What this trial is testing

Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

Who this might be right for
Non Small Cell Lung Cancer
University of California, Irvine 82
Early research (Phase 1)Study completedNCT02009436
What this trial is testing

Azacitidine in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IV Non-Small Cell Lung Cancer
Albert Einstein College of Medicine 8
Testing effectiveness (Phase 2)UnknownNCT05267392
What this trial is testing

Neoadjuvant Immunotherapy With Durvalumab (MEDI4736) in Non-Surgical Early Stage or Locally Advanced Non-Small Cell Lung Cancer (NSCLC) Followed by Radical Radiotherapy or Chemoradiotherapy

Who this might be right for
Non-small Cell Lung Cancer
Instituto Portugues de Oncologia, Francisco Gentil, Porto 30
Large-scale testing (Phase 3)WithdrawnNCT03048136
What this trial is testing

A Safety Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Testing effectiveness (Phase 2)Study completedNCT01160744
What this trial is testing

Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 280
Not applicableNo Longer AvailableNCT01947608
What this trial is testing

Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT01346540
What this trial is testing

A Phase I/II Study of Continuous Oral Treatment With BIBF 1120 Added to Standard Gemcitabine/Cisplatin Therapy in First Line NSCLC Patients With Squamous Cell Histology.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 16
Testing effectiveness (Phase 2)Ended earlyNCT00321308
What this trial is testing

Trial of Pemetrexed With or Without PF-3512676 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small Cell Lung
Pfizer 36
Next Page